BioAge Labs, Inc (BIOA)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $255.03M
Last updated: Nov 17, 2026 at 11:05 AM ET
BioAge Labs, Inc (BIOA) Earnings: Report Dates and Results
BioAge Labs (BIOA) is expected to report earnings on Mar 22, 2027. In the quarter ended Sep 30, 2026, BioAge Labs reported EPS of -$0.73, below the -$0.68 estimate. It beat the EPS estimate in 3 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
BIOA has an expected report date of Mar 22, 2027.
Earnings History
Of the 9 quarters below that had an estimate, BIOA beat 3 and missed 6. Revenue for the quarter ended Sep 30, 2026 was $298000, down 85.5% from $2.05M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.73 | -$0.68 | -$0.69 - -$0.52 | -7.35% | Miss | N/A | 8 | 1 up, 1 down | Nov 5, 2026 | $298000 |
| Jun 30, 2026 | -$0.58 | -$0.65 | -$0.75 - -$0.54 | +10.77% | Beat | N/A | 7 | 1 up, 0 down | Aug 6, 2026 | $2.45M |
| Mar 31, 2026 | -$0.52 | -$0.71 | -$0.74 - -$0.50 | +26.76% | Beat | N/A | 4 | 3 up, 0 down | May 8, 2026 | $2.77M |
| Dec 31, 2025 | -$0.72 | -$0.67 | -$0.76 - -$0.54 | -7.69% | Miss | N/A | 5 | 0 up, 1 down | Mar 24, 2026 | $3.08M |
| Sep 30, 2025 | -$0.56 | -$0.51 | -$0.54 - -$0.50 | -9.80% | Miss | N/A | 3 | 0 up, 3 down | Nov 6, 2025 | $2.05M |
| Jun 30, 2025 | -$0.60 | -$0.38 | N/A | -57.89% | Miss | N/A | N/A | N/A | Aug 6, 2025 | $2.41M |
| Mar 31, 2025 | -$0.36 | -$0.53 | N/A | +32.08% | Beat | N/A | N/A | N/A | May 6, 2025 | $1.45M |
| Dec 31, 2024 | -$1.00 | -$0.66 | N/A | -52.67% | Miss | N/A | N/A | N/A | Mar 20, 2025 | N/A |
| Sep 30, 2024 | -$6.70 | -$0.73 | N/A | -817.81% | Miss | N/A | N/A | N/A | Nov 7, 2024 | N/A |
| Jun 30, 2024 | -$0.60 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 26, 2024 | N/A |
Annual EPS
| Fiscal year ended | EPS | Change |
|---|---|---|
| Sep 30, 2026 | -$1.83 | N/A |
| Jun 30, 2026 | -$1.10 | N/A |
| Dec 31, 2025 | -$2.24 | N/A |
| Dec 31, 2024 | -$8.30 | N/A |
Frequently Asked Questions About BIOA
When is BioAge Labs's next earnings date?
BioAge Labs's next earnings report is expected for Mar 22, 2027.
Did BIOA beat earnings estimates last quarter?
No. BioAge Labs reported EPS of -$0.73 for the quarter ended Sep 30, 2026, below the -$0.68 estimate by 7.35%.
What EPS do analysts expect from BIOA next quarter?
The consensus EPS estimate for BioAge Labs for the quarter ending Dec 31, 2026 is -$0.70 from 13 analysts, with estimates from -$0.81 to -$0.63.
How often does BIOA beat earnings estimates?
BioAge Labs beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -8.23%.
BIOA pages: Overview, Earnings, Forecast, Financials, Competitors